Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Exercise program shows promise for elderly heart failure patients

NCT ID NCT05393362

Disease control Sponsor: University of Malaga Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a 12-week cardiac rehabilitation program in 65 elderly patients (70+) with heart failure. The program included strength and aerobic exercises twice a week. Researchers measured changes in movement, heart function, and fitness. The goal was to see if exercise can improve daily function and heart health in this frail population.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cardiac rehabilitation program (exercise training)
What this could lead to
If successful, this could show that a structured exercise program improves mobility, heart function, and quality of life in elderly heart failure patients.
What could go wrong
This is a small, completed study (65 participants) with no blinding, so results may not apply broadly. Exercise programs also require patient commitment and may not be suitable for all.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

65 people

The number who actually took part.

Started

Mar 2023

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects older than 70 years. * Subjects diagnosed with Heart Failure (HF) followed by the Heart Failure Unit. * Subjects will be able or filling out questionnaires and perform functional tasks; * Clinical stability. * Patients receive optimal treatment. Exclusion Criteria: * Participants with cardiac pathologies that do not have an HF situation * Score on the NYHA scale equal to 4. * Hospitalization in a period of time equal to or less than 3 months. * Score on the Mini-Mental scale (MMSE) below 24. * Inability to get up from the chair at least 5 times * Inability to walk. * Inability to walk independently without a gait assist device (cane, crutch, or walker). * Participation in an experimental study where they receive treatment. * Inability to provide informed consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Comorbidities and coexisting conditions are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

diastolic heart failure heart failure Sarcopenia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Comorbidities and coexisting conditions Frail elderly syndrome Heart failure with preserved ejection fraction Sarcopenia

Contacts and locations

Locations

  • Antonio Cuesta Vargas

    Málaga, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.